Skip to main content

$0.081 0.002 (2.53%)

High

$0.09

Low

$0.08

Trades

83

Turnover

$220,412

Volume

2,818,974
30 June 2023 at 4:10pm
Register to track PTX and receive email alerts.
Subject
PTX Ann: Application for quotation of securities - PTX

PTX Ann: Two PTX abstracts accepted at prestigious ISCT conference

PTX Ann: Initial Director's Interest Notice

PTX Ann: Notification regarding unquoted securities - PTX

PTX Ann: Experienced Pharma Executive Joins Prescient Board

PTX Ann: Notification of cessation of securities - PTX

PTX Ann: Change of Director's Interest Notices x3

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Section 708A Cleansing Notice

PTX Ann: March 2023 Quarterly Update and Appendix 4C

PTX Ann: Change of Director's Interest Notices x2

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Exercise and Expiry of Listed Options

PTX Ann: Continued promising results in PTX-100 TCL trial

PTX Ann: FDA grants broader orphan drug status to PTX100 for TCLs

PTX Ann: Revised Securities Trading Policy

PTX Ann: Appendix 4D and Half Year Financial Report

PTX Ann: Notification of Expiry of Listed Options

PTX Ann: Application for quotation of securities - PTX

PTX Ann: December 2022 Quarterly Update and Appendix 4C

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Change of Director's Interest Notice

PTX Ann: Notification of cessation of securities - PTX

PTX Ann: Section 708A Cleansing Notice

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Results of Annual General Meeting

PTX Ann: AGM Presentation

PTX Ann: Chair's Address to the 2022 Annual General Meeting

PTX Ann: Application for quotation of securities - PTX

PTX Ann: PTX Investor presentation and additional patient response

PTX Ann: September 2022 Quarterly Update and Appendix 4C

PTX Ann: Notice of Annual General Meeting/Proxy Form

PTX Ann: PTX-100 Trial Update

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Section 708A Cleansing Notice

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Change of Director's Interest Notices x2

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Proposed issue of securities - PTX

PTX Ann: Placement Results

PTX Ann: SPP Results and Placement

PTX Ann: Trading Halt

PTX Ann: Extension of Share Purchase Plan

PTX Ann: CellPryme-A Investor Presentation

PTX Ann: PTX unveils CellPryme-A to boost CAR-T performance

PTX Ann: Prescient unveiling CellPryme-A at CAR-TCR summit in Boston

PTX Ann: Application for quotation of securities - PTX

PTX Ann: PTX strategic collaboration with MD Anderson Cancer Center

Register to track PTX and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX